Ranking · Summer 2023 · Healthcare · Drug Discovery and Delivery

Nanograb

Deliver genes to any cell with AI

3.8%

odds of being acquired in the next two years

0.6× the average (6.8%)

#4171 of 4,339 active YC companies · top 97%

Team of 5 · London, England, United Kingdom

Raises the odds

↑ team of 3–5

↑ rewrote its description in the last six months

Lowers the odds

↓ industry: Healthcare

↓ tag: Biotech

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Nanograb's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

nanograb.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub